Tan, IBP back DOH vaccine brand-agnostic policy

House Committee on Health Chairperson Angelina Tan supports the Department of Health's (DOH) 'brand agnostic' policy for COVID-19 vaccinations, which aims to prevent overcrowding at vaccination sites by not announcing specific vaccine brands beforehand.

Tan emphasized that individuals must still be informed of the vaccine they will receive on-site and sign a vaccine-specific informed consent form detailing potential side effects.

This clarifies concerns that the brand-agnostic policy would remove the right to information and potentially lead to vaccine hesitancy.

Integrated Bar of the Philippines (IBP) president Domingo Cayosa stated that while non-prior public disclosure of vaccine brands may be practical, it does not remove a citizen's right to informed consent.

Cayosa added that individuals must be individually appraised about the brand and other details to intelligently consent to or decline the vaccination.

The DOH's suggestion to refrain from announcing vaccine brands was made following incidents of large queues for specific brands like Pfizer.

Topics in this story

Explore more stories about these topics.

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.